Robert R.

Robert R. has a diverse work experience spanning multiple roles and industries. Robert is currently working as the Medical Director of Global Medical Affairs at MJH Life Sciences since June 2023. Prior to that, they served as the Director of Medical Affairs for TTR Amyloidosis at AstraZeneca from June 2022 to May 2023. From November 2019 to June 2022, they were the Clinical Training Director at Axiom. Robert also worked as a Commercial Clinical Training Manager at AstraZeneca from 2018 to 2019 and as a Sr. Scientific Consultant at Prima Physiologica from 2017 to 2018. Before entering the pharmaceutical industry, Robert R. worked in academia as an Associate Professor at Drexel University College of Medicine from 2009 to 2012, and as an Assistant Professor at the University of Delaware from 2003 to 2009. Robert also held research positions at Thomas Jefferson University and E. I. du Pont de Nemours & Co., Inc. from 2000 to 2003 and 1995 to 1999, respectively.

Robert R. holds a Ph.D. in Neuroscience from the University of Pennsylvania School of Medicine, an M.B.A. in Business from the Alfred Lerner College of Business & Economics at the University of Delaware, and a B.S. in Biology from Duquesne University.